AN2 Therapeutics Statistics

Total Valuation

ANTX has a market cap or net worth of $170.62 million. The enterprise value is $117.12 million.

Market Cap	170.62M
Enterprise Value	117.12M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ANTX has 36.00 million shares outstanding. The number of shares has increased by 1.30% in one year.

Current Share Class	36.00M
Shares Outstanding	36.00M
Shares Change (YoY)	+1.30%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	6.03%
Owned by Institutions (%)	24.22%
Float	17.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.48
P/TBV Ratio	3.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.87

Current Ratio	6.87
Quick Ratio	6.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.14% and return on invested capital (ROIC) is -35.31%.

Return on Equity (ROE)	-52.14%
Return on Assets (ROA)	-30.93%
Return on Invested Capital (ROIC)	-35.31%
Return on Capital Employed (ROCE)	-71.59%
Weighted Average Cost of Capital (WACC)	-3.00%
Revenue Per Employee	n/a
Profits Per Employee	-$1.67M
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +279.20% in the last 52 weeks. The beta is -1.32, so ANTX's price volatility has been lower than the market average.

Beta (5Y)	-1.32
52-Week Price Change	+279.20%
50-Day Moving Average	3.19
200-Day Moving Average	1.67
Relative Strength Index (RSI)	71.80
Average Volume (20 Days)	349,015

Short Selling Information

The latest short interest is 633,935, so 1.76% of the outstanding shares have been sold short.

Short Interest	633,935
Short Previous Month	564,275
Short % of Shares Out	1.76%
Short % of Float	3.73%
Short Ratio (days to cover)	1.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.11M
Pretax Income	-35.17M
Net Income	-35.17M
EBITDA	n/a
EBIT	-38.11M
Earnings Per Share (EPS)	-$1.16

Full Income Statement

Balance Sheet

The company has $58.00 million in cash and n/a in debt, giving a net cash position of $58.00 million or $1.61 per share.

Cash & Cash Equivalents	58.00M
Total Debt	n/a
Net Cash	58.00M
Net Cash Per Share	$1.61
Equity (Book Value)	53.06M
Book Value Per Share	1.94
Working Capital	51.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-29.83M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.30%
Shareholder Yield	-1.30%
Earnings Yield	-20.09%
FCF Yield	n/a

Analyst Forecast

The average price target for ANTX is $2.00, which is -57.81% lower than the current price. The consensus rating is "Buy".

Price Target	$2.00
Price Target Difference	-57.81%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1